¿Cómo se comparó el EPS reciente de PMDI con las expectativas?
¿Cómo fue el desempeño de los ingresos de Psychemedics Corp PMDI en el último trimestre?
¿Cuál es la estimación de ingresos para Psychemedics Corp?
¿Cuál es la puntuación de calidad de ganancias de Psychemedics Corp?
¿Cuándo informa Psychemedics Corp sus ganancias?
¿Cuáles son las ganancias esperadas de Psychemedics Corp?
¿Superó Psychemedics Corp las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$1.64
Precio de apertura
$1.63
Rango del día
$1.63 - $1.65
Rango de 52 semanas
$1.45 - $2.44
Volumen
9
Volumen promedio
2.1K
EPS (TTM)
-0.32
Rendimiento de dividendos
0.00%
Cap. de mercado
$10.0M
¿Qué es PMDI?
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 101 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.